A detailed history of Pathway Financial Advisors LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Pathway Financial Advisors LLC holds 2,391 shares of EW stock, worth $156,562. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,391
Previous 2,391 -0.0%
Holding current value
$156,562
Previous $228,000 3.51%
% of portfolio
0.06%
Previous 0.06%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 10, 2024

BUY
$72.54 - $95.56 $173,443 - $228,483
2,391 New
2,391 $228,000
Q2 2023

Jul 18, 2023

BUY
$81.41 - $94.33 $194,651 - $225,543
2,391 New
2,391 $225,000
Q2 2022

Jul 21, 2022

BUY
$86.5 - $128.27 $86 - $128
1 Added 0.04%
2,392 $227,000
Q1 2021

Jun 21, 2021

BUY
$78.68 - $90.67 $188,123 - $216,791
2,391 New
2,391 $222,000
Q3 2018

Jan 16, 2019

SELL
$45.7 - $58.03 $36,422 - $46,249
-797 Closed
0 $0
Q4 2017

May 04, 2018

BUY
$33.79 - $39.39 $26,930 - $31,393
797
797 $90,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Pathway Financial Advisors LLC Portfolio

Follow Pathway Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathway Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathway Financial Advisors LLC with notifications on news.